Lv2
150 积分 2026-01-21 加入
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
5天前
已完结
Age-standardized mortality-to-incidence ratio for prostate cancer in the world
1个月前
已完结
Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up
1个月前
已完结
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
1个月前
已完结
Technical advances in nerve-sparing and continence preservation
1个月前
已完结
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial
1个月前
已完结
Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
1个月前
已完结
European Study of Prostate Cancer Screening — 23-Year Follow-up
1个月前
已完结
A history of prostate cancer treatment
1个月前
已完结
皖公网安备34019202002308
